Agenus | 资产



金融业
股票价格
USD
资产
USD 233.89M
现金及等价物
USD 3.46M
销售成本
USD 137K
流动资产
USD 133.95M
流动负债
USD 287.13M
债务
USD 35.54M
股息收益率
0
EBIT
USD -13.31M
EBITDA
USD -10.11M
员工
389
EPS每股收益
USD -1.03
股本和储备
USD -274.14M
销售毛利
USD 23.93M
债务利息支出
USD 12.8M
贷款资金
USD 23.6M
市值
USD 1.28B
净收入
USD -25.27M
营业费用
USD -274.14M
营业利润
USD -13.31M
普通股股本
USD 266K
PE价格收益
17.82
税前利润
USD -274.14M
销售收入
USD 24.07M
销售和管理费用
USD 23.6M
贸易债权人
USD 85.29M
应收帐款人
USD 354K


资产 更改 日
AbbVie USD 133.9B 3.28B 2025-09
Agenus USD 233.89M 48.67M 2025-09
Amgen USD 90.59B 445M 2025-12
AstraZeneca USD 114.46B 2.03B 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Celldex Therapeutics USD 648.44M 43.97M 2025-09
CSL USD 39.4B 957M 2025-06
Dynavax Technologies USD 946.51M 28.06M 2025-09
Eli Lilly USD 114.94B 14.01B 2025-09
Gilead Sciences USD 58.53B 2.81B 2025-09
GlaxoSmithKline GBP 61.12B 221M 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Incyte USD 6.96B 627.62M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
J&J USD 192.82B 573M 2025-09
Jiangsu Hengrui CNY 68.33B 5.43B 2025-09
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
MacroGenics USD 270.76M 25.34M 2025-09
Merck EUR 50.93B 3.58B 2025-09
Merck USD 129.55B 12.02B 2025-09
Novartis USD 107.29B 2.89B 2025-09
Novavax USD 1.18B 156.66M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Veracyte USD 1.37B 23.68M 2025-09


Agenus 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.